Mevion Medical Systems

company

About

Mevion Medical Systems develops radiation therapies for the treatment of cancer.

  • 101 - 250

Details

Last Funding Type
Private Equity(PE)
Last Funding Money Raised
$55M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2004
Number Of Employee
101 - 250
Operating Status
Active

Mevion Medical Systems, Inc. (formerly Still River Systems, Inc.) is a radiation therapy company dedicated to advancing the treatment of cancer. As the pioneering developer of modern proton therapy systems, Mevion provides innovative, safe, and effective solutions by transforming advances in medical technology and science into practical clinical reality.

Mevion’s flagship product, the MEVION S250 Proton Therapy System, is designed to preserve all of the treatment benefits of traditional proton therapy systems while removing the obstacles of size, cost, and complexity. Realizing this vision, Mevion has forever changed the economics and accessibility of proton therapy worldwide.

Founded in 2004, Mevion is a privately held company headquartered in the Boston metropolitan area with international offices in the United Kingdom and Japan.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$444.90M
Mevion Medical Systems has raised a total of $444.90M in funding over 2 rounds. Their latest funding was raised on Jun 14, 2018 from a Private Equity(PE) round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 14, 2018 Private Equity(PE) $150M 2 Detail
Aug 4, 2014 Private Equity(PE) $200M 2 Detail
Jun 25, 2013 Private Equity(PE) $55M 1 Detail
Jan 1, 2009 Series Unknown $33M 1 Detail
Oct 8, 2007 Series C $6.90M 1 Detail

Investors

Number of Lead Investors
Number of Investors
3
Mevion Medical Systems is funded by 3 investors. Henan Maisheng Medical Technology and HOPU Investment Management Company are the most recent investors.
Investor Name Lead Investor Funding Round
Henan Maisheng Medical Technology Private Equity(PE)
HOPU Investment Management Company Private Equity(PE)
Caxton Advantage Life Sciences Fund Private Equity(PE)